Health Policy
WHO guidelines, EU directives, and Georgian health governance
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Health Policy
Beyond the Breakthrough: Pancreatic Cancer Researchers Warn Real Work Is Just Beginning
A new STAT News commentary warns that while breakthrough pancreatic cancer drugs offer promise, the…
Why Nearly Half of U.S. Counties Lack Maternity Care Despite Falling Birth Rates
Nearly 50% of U.S. counties lack an obstetrician-gynecologist despite falling birth rates. This geographic crisis…
Eight Years On: Refugee and Migrant Health Progress Remains Slow Despite COVID-19 Proof of Concept
The UCL–Lancet Commission's latest review in The Lancet finds that progress toward refugee and migrant…
The Sandwich Generation: Balancing Child and Elder Care in Modern Healthcare
The sandwich generation—adults balancing childcare and elder care—faces mounting stress and fragmented support systems. Healthcare…
UK Updates Influenza Vaccine Delivery Framework for 2024–25 Seasonal Campaign
The UK Department of Health and Social Care has released an updated Group Direction template…